Amgen's Nplate(R) Maintains Platelet Counts for More Than Five Years in Adults With Chronic ITP Read more about Amgen's Nplate(R) Maintains Platelet Counts for More Than Five Years in Adults With Chronic ITP
Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting Read more about Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting
FDA Approves Amgen's XGEVA(TM) (Denosumab) for the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors Read more about FDA Approves Amgen's XGEVA(TM) (Denosumab) for the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors
Amgen Foundation and Ashoka's Changemakers Announce Finalists in Patients | Choices | Empowerment Competition Read more about Amgen Foundation and Ashoka's Changemakers Announce Finalists in Patients | Choices | Empowerment Competition
Call for Applications: The Amgen Award for Science Teaching Excellence Read more about Call for Applications: The Amgen Award for Science Teaching Excellence
Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits Read more about Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits
Study Published in New England Journal of Medicine Shows Nplate(R) Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP Read more about Study Published in New England Journal of Medicine Shows Nplate(R) Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP
Amgen Scholars Undergraduate Summer Research Program Begins Phase 2 Read more about Amgen Scholars Undergraduate Summer Research Program Begins Phase 2
Amgen to Present at 19th Annual Credit Suisse Healthcare Conference Read more about Amgen to Present at 19th Annual Credit Suisse Healthcare Conference
Published Results Show Denosumab Superior to Zometa(R) in Delaying or Preventing Bone Complications in Patients With Bone Metastases From Advanced Breast Cancer Read more about Published Results Show Denosumab Superior to Zometa(R) in Delaying or Preventing Bone Complications in Patients With Bone Metastases From Advanced Breast Cancer
